Form D — Galvanize Therapeutics, Inc.
0001659073-26-000004 · filed Nov 18, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $136,185,232
- Reported amount sold
- $136,185,232
- Minimum investment
- $0
- Investors
- 26
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Galvanize Therapeutics, Inc.
- CIK
- 1659073
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3200 BRIDGE PARKWAY
REDWOOD CITY, California 94065 - Phone
- 650-268-4252
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Doug Godshall · Executive OfficerRedwood City, California Find on LinkedIn ↗
-
Seth Harrison · DirectorRedwood City, California Find on LinkedIn ↗
-
Antoine Papiernik · DirectorRedwood City, California Find on LinkedIn ↗
-
Zack Scott · DirectorRedwood City, California Find on LinkedIn ↗
-
David Lewis · DirectorRedwood City, California Find on LinkedIn ↗
-
Steve Anheier · Executive OfficerRedwood City, California Find on LinkedIn ↗
-
Isaac Zacharias · DirectorRedwood City, California Find on LinkedIn ↗
-
Laura Francis · DirectorRedwood City, California Find on LinkedIn ↗
-
Garheng Kong · DirectorRedwood City, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗